Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein
- PMID: 9371609
- PMCID: PMC230253
- DOI: 10.1128/JVI.71.12.9475-9481.1997
Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein
Abstract
The sequence variability of viral structure polypeptides has been associated with immune escape mechanisms. The V1 region of simian immunodeficiency virus (SIV) is a highly variable region of the SIVmac env gene. Here, we describe the V1 region as a linear neutralizing epitope. V1 region-specific neutralizing antibodies (NAb) were first demonstrated in a rabbit infected with a recombinant vaccinia virus carrying the env gene of human immunodeficiency virus type 2 strain ben (HIV-2ben). Since we detected in this animal V1 region-specific NAb that were able to neutralize not only human immunodeficiency virus type 2 but also SIVmac32H, we investigated whether a similar immune response is evoked in macaques (Macaca mulatta) either infected with SIVmac or immunized with the external glycoprotein (gp130) of the same virus. Distinctly lower NAb titers were found in the SIVmac-infected animals than in the gp130-immunized macaques. Since the NAb titers in both groups were high enough for competition experiments, we used five overlapping peptides encompassing the whole V1 region for a detailed identification of the epitope. In each of the 12 macaques investigated, we detected a high level of NAb reacting with at least one peptide located in the central part of the V1 region. The relatively high degree of divergence, especially within the central part of the V1 region, which characterized the evolution of the retroviral sequences from the original inoculum in the infected macaques suggests the development of escape mutants. Furthermore, 3 of 12 animals developed NAb directed against the amino-terminal end of the V1 region epitope. Sequence analysis, however, revealed relatively low levels of genetic drift and genetic variability within this part of the V1 region. The induction of V1 env-specific NAb not only in gp130-immunized macaques but also in SIVmac-infected animals in combination with the increased genetic variability of this region in vivo indicates a marked biological significance of this epitope for the virus.
Similar articles
-
Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.J Virol. 2004 Apr;78(7):3561-71. doi: 10.1128/jvi.78.7.3561-3571.2004. J Virol. 2004. PMID: 15016879 Free PMC article.
-
Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):751-60. doi: 10.1089/aid.1998.14.751. AIDS Res Hum Retroviruses. 1998. PMID: 9643375
-
An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation.AIDS Res Hum Retroviruses. 1993 May;9(5):423-30. doi: 10.1089/aid.1993.9.423. AIDS Res Hum Retroviruses. 1993. PMID: 7686386
-
Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.Virology. 2001 Nov 10;290(1):59-73. doi: 10.1006/viro.2001.1144. Virology. 2001. PMID: 11883006
-
Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence.Curr Top Microbiol Immunol. 1994;188:185-219. doi: 10.1007/978-3-642-78536-8_11. Curr Top Microbiol Immunol. 1994. PMID: 7523031 Review.
Cited by
-
Naturally occurring V1-env region variants mediate simian immunodeficiency virus SIVmac escape from high-titer neutralizing antibodies induced by a protective subunit vaccine.J Virol. 2000 Dec;74(23):11145-52. doi: 10.1128/jvi.74.23.11145-11152.2000. J Virol. 2000. PMID: 11070011 Free PMC article.
-
Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain.J Virol. 2003 Jan;77(1):208-16. doi: 10.1128/jvi.77.1.208-216.2003. J Virol. 2003. PMID: 12477826 Free PMC article.
-
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen.J Virol. 1999 Jan;73(1):618-30. doi: 10.1128/JVI.73.1.618-630.1999. J Virol. 1999. PMID: 9847367 Free PMC article.
-
Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeys.J Virol. 2010 Jan;84(2):953-63. doi: 10.1128/JVI.01679-09. Epub 2009 Nov 11. J Virol. 2010. PMID: 19906933 Free PMC article.
-
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.PLoS Pathog. 2016 Jul 19;12(7):e1005742. doi: 10.1371/journal.ppat.1005742. eCollection 2016 Jul. PLoS Pathog. 2016. PMID: 27434311 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources